Clinical Trials Directory

Trials / Sponsors / Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Pa
Urticaria Chronic
Phase 22024-11-26
TerminatedA Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in
Allergic Asthma
Phase 12024-11-26
TerminatedA Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briqui
Chronic Inducible Urticaria
Phase 1 / Phase 22024-03-18
Active Not RecruitingDose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquili
Chronic Spontaneous Urticaria
Phase 1 / Phase 22023-11-29
TerminatedJSP191 (briquilimab) in Subjects with LR-MDS
Lower-risk Myelodysplastic Syndrome
Phase 12023-06-19
UnknownJSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transpla
MYELODYSPLASTIC SYNDROME; MDS, ACUTE MYELOID LEUKEMIA; AML
Phase 12020-07-08
TerminatedJSP191 Antibody Targeting Conditioning in SCID Patients
SCID
Phase 1 / Phase 22017-03-20